Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Moberg Pharma AB sell BiotechBee

Moberg Pharma AB
Start price
€2.37
13.05.24 / 70%
Target price
€1.50
31.05.26
Performance (%)
-0.84%
End price
€2.35
14.05.24
Summary
This prediction ended on 14.05.24 with a price of €2.35. The SELL prediction by BiotechBee for Moberg Pharma AB closed nearly unchanged from the start price. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Moberg Pharma AB 6.034% 6.034% 12.329%
iShares Core DAX® 1,00 % 4,83 % 8,15 %
iShares Nasdaq 100 2,70 % -1,72 % 26,92 %
iShares Nikkei 225® 3,52 % -3,51 % 48,06 %
iShares S&P 500 1,77 % 1,27 % 23,58 %

According to BiotechBee what are the pros and cons of Moberg Pharma AB for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Moberg Pharma AB diskutieren
Prediction Sell
Perf. (%) -0.84%
Target price 1.500
Change
Ends at 31.05.26

Sell mit Kursziel 1,5

BiotechBee 
0
Report Share
13.05.24
In the thread Trading Moberg Pharma AB
Prediction Sell
Perf. (%) -0.84%
Target price 1.500
Change
Ends at 31.05.26

Sell beendet

BiotechBee 
0
Report Share
14.05.24